Lonigutamab (Anti-IGF1R / CD221)
Lonigutamab (hz208F2-4) is a humanized monoclonal antibody against the insulin-like growth factor-1 receptor (IGF-1R) with the potential to treat thyroid eye disease (TED). MW: 146.26 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2926 |
| Sku # | A2926-1mg*25 |
| Pricing | 1mg*25, $5070.00 |